Bone Therapeutics SA: Transparency notification received from CPH Banque
PRESS RELEASE – REGULATED INFORMATION
See the original post here:
Bone Therapeutics SA: Transparency notification received from CPH Banque
Medcolcanna Organics Inc. Announces Closing of Upsized Convertible Debenture Financing
BOGOTÁ, Colombia, Dec. 24, 2020 (GLOBE NEWSWIRE) -- Medcolcanna Organics Inc. (“Medcolcanna”, “MCCN” or the “Company”) (NEO: MCCN), a leading Colombian and globally integrated cannabis company, is pleased to announce that it has closed on the second and final tranche of its previously announced offering of convertible debentures as per the press release dated August 28, 2020, raising gross aggregate proceeds of $0.25 million, bringing the total amount raised pursuant to this offering to $1.25 million, being the full amount previously disclosed. The offering consists of convertible secured debentures (the “Debentures”). The Debentures are convertible into common shares in the capital of the Company (“Common Shares”) on the following terms: the Debentures are issuable in $1,000 increments and are convertible into Common Shares at a price of $0.20 per share (meaning 5,000 shares may be issued on the conversion of each Debenture) and will have a term of two (2) years from the date of issuance, with interest payable twice yearly of fourteen percent (14%) per annum (simple not compounded), payable in cash or shares. The Debentures will be subject to earlier redemption by the Company in the event the Common Shares are trading on the facilities of the Neo Exchange Inc. (or such other stock exchange on which the Common Shares may then be trading) at a volume weighted average trading price at or above $0.40 per share for a period of not less than ten (10) consecutive trading days.
Follow this link:
Medcolcanna Organics Inc. Announces Closing of Upsized Convertible Debenture Financing
Tauriga Sciences Inc. Funds the Entirety of the Master Services Agreement that it Recently Entered Into with CSTI
The Company has Now Resumed the Clinical Development of its Proposed Anti-Nausea Pharmaceutical Grade Version of Tauri-Gum™
Continued here:
Tauriga Sciences Inc. Funds the Entirety of the Master Services Agreement that it Recently Entered Into with CSTI
BioStem Technologies, Announces Filing of 2020 Quarterly Reports
Pompano Beach, Fl, Dec. 24, 2020 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC PINK: BSEM) ("BioStem" or the "Company"), a leading life sciences company specializing in perinatal tissue allografts for use in regenerative therapies, today announced that it has filed its quarterly reports for 2020 to become current with OTC Markets.
The rest is here:
BioStem Technologies, Announces Filing of 2020 Quarterly Reports
MedMira Reports First Quarter Results FY2021
HALIFAX, Nova Scotia, Dec. 24, 2020 (GLOBE NEWSWIRE) -- MedMira Inc. (MedMira) (TSXV: MIR), reported today on its financial results for the quarter ended October 31, 2020.
Read more here:
MedMira Reports First Quarter Results FY2021
Global Neural Stem Cells Market 2020-2026 updated Report with the latest scenarios based on the global COVID-19 Pandemic – Farming Sector
Global Neural Stem Cells Market Forecast 2026- Research Report(Download Free Sample) discusses the demand, gross margin, sales, and market share of the Neural Stem Cells Industry. The growth drivers, trends, and developments in the Neural Stem Cells industry are explained. The Neural Stem Cells Report presents the company profiles of top market players, with a complete analysis of production, revenue share, price structures, and gross margin analysis from 2015-2019. Also, the Neural Stem Cells markets served and the geographical presence of these top players is explained in detail.
The report begins with the Neural Stem Cells Market overview, scope, market size estimation, and growth rate by Neural Stem Cells Product type. Also, top Applications in Neural Stem Cells Market are studied in this report. The next segment analyzes the capacity, production, pricing structures, and market trends from 2015-2026. The top Neural Stem Cells Industry trends and market driving forces with the analysis of market risks are studied.
Request A Free Sample Report Here: https://globalmarketers.biz/report/life-sciences/global-neural-stem-cells-market-report-2020-by-key-players,-types,-applications,-countries,-market-size,-forecast-to-2026-(based-on-2020-covid-19-worldwide-spread)/158606#request_sample
Leading Players List:
Cellular Dynamics International Stemedica Cell Technologies Inc Fibrocell Science Inc Corestem Inc, Corning Inc. Celgene Corporation Kangstem Biotech Ltd Ge Healthcare Biotime Inc Thermo Fisher Vericel Corporation Cellular Engineering Technologies Inc Brainstorm Cell Therapeutics Cytori Therapeutics Becton Dickinson Takara Holdings Inc.
The latest product launch events, mergers & acquisitions in Neural Stem Cells, and expansion plans are listed. The geographical regions/countries namely United States, Europe, China, Japan, South Korea, India, Southeast Asia, and the rest. Further, regional regional bifurcation includes the Neural Stem Cells market presence in the countries namely United States, Canada, Mexico, UK, Italy, Russia, France, Germany, Australia, Thailand, Indonesia, Vietnam, Philippines, Brazil, Central & South America, and Middle East & Africa. In the Middle East & Africa, the top countries analyzed are Egypt, South Africa, and the Gulf countries.
The christmas and Year-End Sale is on Live on selected Reports. Ask For Discount :https://globalmarketers.biz/discount_inquiry/discount/158606
Global Neural Stem Cells Market segments:
Global Neural Stem Cells Market By Type:
Neural Crest Stem Cell(NC-SC) CNS Stem Cells(CNS-SC)
Global Neural Stem Cells Market By Application:
Neurodevelopmental Repair damaged nerve tissue Others
In the next segment, Neural Stem Cells Market value chain and sales channel analysis are conducted to present information on upstream suppliers and downstream buyers. The opportunities and challenges in Neural Stem Cells Market and factors affecting the market growth are analyzed in depth. The forecast Neural Stem Cells Market analysis explains the growth rate, consumption, capacity, and expected revenue analysis. Lastly, data sources, research methodology, and analyst views are explained.
Research Methodology: The Global Neural Stem Cells Market Report is formulated by using top-down and bottom-up research methodology. The global market is fragmented into segments to provide regional and country-level analysis. Numerous surveys and detailed primary research is conducted to present Neural Stem Cells Market estimation, applications, and growth. The Neural Stem Cells market scope is analyzed across different geographies. Detailed mapping of major Neural Stem Cells manufacturers, applications, and product types is conducted for analyzing potential clients. The annual Neural Stem Cells Market revenue is calculated from annual reports, paid primary interviews, and secondary data sources.
Inquiry Before Purchasehttps://globalmarketers.biz/report/life-sciences/global-neural-stem-cells-market-report-2020-by-key-players,-types,-applications,-countries,-market-size,-forecast-to-2026-(based-on-2020-covid-19-worldwide-spread)/158606#inquiry_before_buying
The key developments in Neural Stem Cells Industry, company overview, SWOT analysis, and market drivers are estimated to offer Neural Stem CellsMarket overview. The most crucial part of Neural Stem Cells Report which is a competitive vendor landscape profile offers a detailed performance of top players and their growth trends. Also, the business tactics and strategies implement by major Neural Stem Cells Industry players are profiled in this study. Our research study will help the renowned and emerging Neural Stem Cells Market players to understand industry competition and development aspects.
Global Neural Stem Cells Market Research Report Serves The Following Purpose: To state the Neural Stem Cells sales price, revenue, market share, size, and value from 2015-2019 and 2020-2026 To study top Neural Stem Cells Market players and analyze their geographical presence, competitive profile, and gross margin analysis. To analyze the Neural Stem Cells market scope across top regions namely North America, Europe, Asia-Pacific, Middle East & Africa, Central & South America, and rest of the world. To present mergers & acquisitions, expansion plans, future scope, and development status. To present SWOT analysis, Neural Stem Cells market drivers, threats, and risk assessment. The complete evaluation of pricing structure, stakeholders, manufacturers, dealers, traders, and distributors is conducted. To study forecasts Neural Stem Cells Industry prospects like market value, volume, consumption, and regional scope from 2020-2026. Valuable data sources, research methodology, analyst views, and suggestions are offered.
Originally posted here:
Global Neural Stem Cells Market 2020-2026 updated Report with the latest scenarios based on the global COVID-19 Pandemic - Farming Sector
Organ and Tissue Transplantation and Alternatives – GlobeNewswire
December 21, 2020 04:14 ET | Source: ReportLinker
New York, Dec. 21, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Organ and Tissue Transplantation and Alternatives" - https://www.reportlinker.com/p096592/?utm_source=GNW g., kidneys, liver, heart-lung, pancreas, intestines) and the tissue transplantation (e.g., bone, skin, cornea, heart valve) markets, along with the pharmaceuticals that accompany each market.
Also included are experimental xenografts and artificial organs; tissue transplants; and cell transplants (e.g., bone marrow, cord blood, peripheral blood, islet cell). The report touches on the use of fetal cells, stem cells and altered cancer cells.
The arrangement of this report offers an overview of the key elements in the transplantation process: tissue typing, procurement and preservation, immunosuppressants for solid organ and tissue transplants, and postoperative monitoring. International markets are discussed, and information is provided on industry structure and the regulatory environment.
Within each section are discussions of commercialization opportunities for each segment of the market. New or emerging devices, techniques and pharmaceuticals are highlighted.
Profiles of leading companies involved with solid organ transplantation, tissue transplantation, and alternative technologies are included. The report provides information on company placement within the market and strategic analyses of the companies available and emerging products.
An appendix featuring various terms and processes used in transplantation is provided at the end of the report.
This report cites autologous products only in relation to their impact on the market for allografts. It does not include blood products, except for peripheral and umbilical cord blood as a source of stem cells.
By geography, the market has been segmented into the North America, Europe, Asia-Pacific, and Rest of the World regions. Detailed analysis of the market in major countries such as the U.S., Germany, the U.K., Italy, France, Spain, Japan, China, India, Brazil, Mexico, GCC countries and South Africa will be covered in the regional segment. For market estimates, data will be provided for 2019 as the base year, with estimates for 2020 and forecast value for 2024.
Report Includes: - 26 data tables and 37 additional tables - An overview of the global organ and tissue transplantation and alternatives market - Estimation of the market size and analyses of market trends, with data from 2018 to 2019, estimates for 2020 and projection of CAGR through 2024 - Details about organ and tissue transplantation and alternatives, their pathophysiology and affects, and major advancement and latest trends - A look at the regulatory scenarios and initiatives by government organization - Analysis of current and future market dynamics and identification of key drivers, restraints and opportunities such as increasing incidence of organ donations, improved awareness about organ donations, side effects of organ and tissue transplantation and antibiotic resistance infections - Coverage of emerging procedures and products in development and discussion on prevalence of major chronic diseases which initiates organ damage or donation - Discussion on the role of the organ procurement organization and information on transplantation process and preparation and coverage of issues like black market donors - Impact analysis of COVID-19 on organ and tissue transplantation and alternatives market - Market share analysis of the key companies of the industry and coverage of events like mergers & acquisitions, joint ventures, collaborations or partnerships, and other key market strategies - Company profiles of major players of the industry, including Abiomed Inc., Bayer AG, F. Hoffmann-La Roche & Co., Johnson & Johnson, Novartis AG, Pfizer Inc. and XVIVO Perfusion
Summary: The global organ and tissue transplantation and alternatives market was valued at REDACTED in 2019.The market is expected to grow at a compound annual growth rate (CAGR) of REDACTED to reach approximately REDACTED by 2024.
Growth of the global market is attributed to factors such as the growing prevalence of obesity, diabetes, cancer, and other chronic diseases which leads to organ damage, a strong product regulatory scenario, and strong investment in research and development activities by key market players including Abbott Laboratories, Cryolife Inc., Bristol-Myers Squibb, Novartis Ag, F. Hoffmann-La Roche Ltd., Medtronic, Arthrex Inc., Depuy Synthes (Johnson & Johnson), and Allosource.
Although various factors facilitate the global market for organ and tissue transplantation and alternatives, certain parameters such as challenges in HLA sequencing and gaps in supply and demand can constrain market growth.For instance, although there is an increasing need for organ transplants, the shortage of organs worldwide limits the number of transplant procedures performed, and in turn creates an impact on transplant diagnostics procedures.
An increasing number of candidates on the waiting list for organ transplant procedures worldwide further widens this gap of availability and requirement of organs for transplant purposes.
Successful organ and tissue transplantation began to arrive in the mid-1970s when tissue typing coupled with the use of cyclosporine provided more successful graft and patient survival. Today, patient and graft survival for kidney transplants is higher than 90% for the first year post-transplant, and often the success rate is 80% to 90% for five years post-transplant, with some recipients living more than 20 years after their transplant.
Continuing developments in organ procurement, organ preservation, tissue typing, and immunosuppressant use have bolstered successful transplantation surgical techniques. Evolving posttransplant drug and testing regimens have added to the success rate with close post-transplant monitoring and immunosuppressant dosage review. Read the full report: https://www.reportlinker.com/p096592/?utm_source=GNW
About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.
__________________________
Go here to read the rest:
Organ and Tissue Transplantation and Alternatives - GlobeNewswire
Report On Canine Stem Cell Therapy Market to 2026: (Industry Insights, Company Overview and Investment Analysis) – Farming Sector
Canine Stem Cell Therapy Market report shows the Industry Chain Structure as well as Macroeconomic Environment Analysis and Development Trend. The Canine Stem Cell Therapy Market report also provides the market impact and new opportunities created due to the COVID19/CORONA Virus catastrophe. The total market is further divided by company, by country, and by application/types for the competitive landscape analysis. The report then estimates 2020-2026 market development trends of Canine Stem Cell Therapy Industry.
TheCanine Stem Cell Therapy market report gives CAGR value, Industry Chains, Upstream, Geography, End-user, Application, Competitor analysis, SWOT Analysis, Sales, Revenue, Price, Gross Margin, Market Share, Import-Export, Trends and Forecast. The report also gives insight on entry and exit barriers of the industry.
Get Exclusive Sample of Report on Canine Stem Cell Therapy market @ https://www.alltheresearch.com/sample-request/206
The Canine Stem Cell Therapy Market Report Covers Major Players:
Canine Stem Cell Therapy Market Breakdown Data by its type
Canine Stem Cell Therapy Market Breakdown Data by its Application
Canine Stem Cell Therapy Consumption Breakdown Data by Region: North America, United States, Canada, Mexico, Asia-Pacific, China, India, Japan, South Korea, Australia, Indonesia, Malaysia, Philippines, Thailand, Vietnam, Europe, Germany, France, UK, Italy, Russia, Rest of Europe, Central & South America, Brazil, Rest of South America, Middle East & Africa, GCC Countries, Turkey, Egypt, South Africa, Rest of Middle East & Africa.
The Study Objectives of Canine Stem Cell Therapy Market Report are:
Any Customization required? Request here @ https://www.alltheresearch.com/customization/206
Major Points from Table of Contents:
Ask Your Queries to our Analyst regarding Canine Stem Cell Therapy Report @ https://www.alltheresearch.com/speak-to-analyst/206 Frequently Asked Questions:
FOR ALL YOUR RESEARCH NEEDS, REACH OUT TO US AT:
Contact Name: Rohan
Email: [emailprotected]
Phone: +1 (407) 768-2028
Read this article:
Report On Canine Stem Cell Therapy Market to 2026: (Industry Insights, Company Overview and Investment Analysis) - Farming Sector